CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in OVID — Ovid Therapeutics Inc.
CIK 884546
SAN FRANCISCO, CA
Position in OVID
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,194,472
+$1,034,632 QoQ
Shares Held
444,042
+516.7% QoQ
Ownership
0.227%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#34
of 130 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OVID Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. OVID ranks #217 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in OVID
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,194,472 | 444,042 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $159,840 | 72,000 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $42,271 | 135,487 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $151,128 | 161,808 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $190,933 | 161,808 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $124,430 | 161,808 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $493,514 | 161,808 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $521,021 | 161,808 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $652,938 | 170,036 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $533,482 | 162,647 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $91,946 | 35,638 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $36,180 | 19,452 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $35,791 | 19,452 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $41,821 | 19,452 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $61,079 | 19,452 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $62,440 | 19,452 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $65,358 | 19,452 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $76,057 | 19,452 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $477,487 | 118,778 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $249,207 | 107,882 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $559,299 | 97,439 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $743,271 | 100,851 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $55,362 | 18,578 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||